Clinical Trials Sponsored by Groupe Cooperateur Multidisciplinaire en Oncologie (GERCOR)

Total 88 results

GERCOR - Multidisciplinary Oncology Cooperative...

Recruiting

Watch-and-Wait Approach With Dostarlimab in Localized dMMR/MSI-H Gastric Cancer: GERCOR Phase II Study (DEWI)

Gastric Adenocarcinoma | Adenocarcinoma - GEJ

France
GERCOR - Multidisciplinary Oncology Cooperative...

Recruiting

ctDNA in CRC Patients Undergoing Curative-intent Surgery for Liver Metastases (CLIMES)

Metastatic Colorectal Cancer | Circulating Tumor DNA

France
GERCOR - Multidisciplinary Oncology Cooperative...

Active, not recruiting

QoL in mCRC Elderly Patients Receiving First-line Therapy Based on Simplified Geriatric Parameters. (COLAGE)

Quality of Life | Metastatic Colorectal Cancer | Elderly Patients

France
GERCOR - Multidisciplinary Oncology Cooperative...

Active, not recruiting

Evaluation of an Adapted Physical Activity Program in Patients With Unresectable Pancreatic Cancer

Metastatic Pancreatic Cancer | Unresectable Locally Advanced Cancer

France
GERCOR - Multidisciplinary Oncology Cooperative...

Completed

Cetuximab and Combination Chemotherapy in Patients With Stage III-IV Resectable Oropharynx Cancer (ECHO-07)

Head and Neck Cancer

France
GERCOR - Multidisciplinary Oncology Cooperative...

Completed

Evaluation of Treatment Response With CHOI and RECIST Criteria and CT Texture Analysis in Patients With Metastatic Colorectal Cancer Treated With Regorafenib (TEXCAN)

Metastatic Colorectal Cancer

France
GERCOR - Multidisciplinary Oncology Cooperative...

Completed

A Study of Sunitinib in Patients With Advanced Cholangiocarcinoma (SUN-CK)

Unresectable and Advanced Cholangiocarcinoma

France
GERCOR - Multidisciplinary Oncology Cooperative...

Completed

Combination Chemotherapy in Treating Older Patients With Solid Tumour, (OLD)

Solid Tumor Regardless of Localization and Stage

France
GERCOR - Multidisciplinary Oncology Cooperative...

Not yet recruiting

First-line EXL01 With Nivolumab and FOLFOX for PD-L1 CPS ≥5 Metastatic Gastric Cancer (BIG)

Gastric Cancer
GERCOR - Multidisciplinary Oncology Cooperative...

Recruiting

Acupuncture for Oxaliplatin-induced Peripheral Neuropathy in Gastro-intestinal Cancer Patients (ACUPOX)

Gastric Cancer | Colorectal Cancer | Pancreas Cancer | Liver Cancer | Esophagus Cancer

France
GERCOR - Multidisciplinary Oncology Cooperative...

Recruiting

Prognostic and Predictive Markers of Treatment Response in Patients With PAC. (CANOPE)

Pancreatic Adenocarcinoma

France
GERCOR - Multidisciplinary Oncology Cooperative...

Recruiting

Prognostic and Predictive Markers of Response to Treatment in Patients With Bile Duct Cancer: ACABi PRONOBIL Study

Biliary Tract Cancer

France
GERCOR - Multidisciplinary Oncology Cooperative...

Not yet recruiting

Effects of Combining a Neuromuscular Electrical Stimulation Intervention With Nutritional Support in Deconditioned Patients With Advanced Gastrointestinal Cancer

Cancer Digestive

France
GERCOR - Multidisciplinary Oncology Cooperative...

Active, not recruiting

LONsurf and G-CSF Use: Being On A Right Dose-intensity to Optimize Treatment Efficacy (LONGBOARD)

Metastatic Colorectal Cancer

France
GERCOR - Multidisciplinary Oncology Cooperative...

Active, not recruiting

Combination Chemotherapy for 3 Months or 6 Months in Treating Patients With Stage III Colon Cancer (IDEA)

Colorectal Cancer

France
GERCOR - Multidisciplinary Oncology Cooperative...

Completed

Panitumumab and Irinotecan as Third-Line Therapy in Treating Patients With Metastatic Colorectal Cancer (PIMABI)

Colorectal Cancer

France
GERCOR - Multidisciplinary Oncology Cooperative...

Unknown

Management of Symptomatic Advanced Pancreatic Adenocarcinoma

Pancreas | Management Supportive Care Program

France
GERCOR - Multidisciplinary Oncology Cooperative...

Completed

Everolimus, Carboplatin, and Paclitaxel in Locally Advanced Head and Neck Cancer That Cannot Be Removed by Surgery (CAPRA)

Head and Neck Cancer

France
GERCOR - Multidisciplinary Oncology Cooperative...

Completed

Optimized Chemotherapy Followed by Maintenance With Bevacizumab With or Without Erlotinib in Treating Patients With Metastatic Colorectal Cancer That Cannot be Removed by Surgery (DREAM) (DREAM)

Colorectal Cancer

France, Austria, Canada
GERCOR - Multidisciplinary Oncology Cooperative...

Terminated

Chemotherapy With or Without Dalteparin in Treating Patients With Metastatic Pancreatic Cancer (PAM07)

Pancreatic Cancer | Thromboembolism | Chemotherapeutic Agent Toxicity

France
GERCOR - Multidisciplinary Oncology Cooperative...

Completed

Combination Chemotherapy in Treating Patients With Colorectal Cancer and Resectable Metastases (MIROX)

Colorectal Cancer | Chemotherapy | Metastatic Cancer

France
GERCOR - Multidisciplinary Oncology Cooperative...

Not yet recruiting

POP-UP: a Single-arm, Two-cohort Study: Trimodal Prehab for Upper GI and Pancreatic Cancer (POP-UP)

Esophageal Cancer | Pancreatic Ductal Adenocarcinoma
GERCOR - Multidisciplinary Oncology Cooperative...

Recruiting

Nivolumab and Ipilimumab in Patients With dMMR and/or MSI Metastatic Colorectal Cancer Resistant to Anti-PD1 Monotherapy (NIPIRESCUE)

Metastatic Colorectal Cancer

France
GERCOR - Multidisciplinary Oncology Cooperative...

Terminated

Metabolic Radiotherapy After Complete Resection of Liver Metastases in Patient With Digestive Neuroendocrine Tumor (TERAVECT)

Liver Metastases | Resection | Digestive Neuroendocrine Tumors | Metabolic Radiotherapy

France
GERCOR - Multidisciplinary Oncology Cooperative...

Terminated

Rechallenge of Cetuximab Combined With Irinotecan as Third-line Chemotherapy in Patients With Metastatic Colorectal Cancer - Phase II Study (REGAIN)

Colorectal Cancer Metastatic

France
GERCOR - Multidisciplinary Oncology Cooperative...

Completed

Gemcitabine With or Without Capecitabine and/or Radiation Therapy or Gemcitabine With or Without Erlotinib in Treating Patients With Locally Advanced Pancreatic Cancer That Cannot Be Removed by Surgery

Pancreatic Cancer

France
GERCOR - Multidisciplinary Oncology Cooperative...

Terminated

Liposome-encapsulated Irinotecan Hydrochloride PEP02 or Irinotecan Hydrochloride, Leucovorin Calcium, and Fluorouracil as Second-Line Therapy in Treating Patients With Metastatic Colorectal Cancer (PEPCOL)

Colorectal Cancer

France
GERCOR - Multidisciplinary Oncology Cooperative...
Sanofi

Completed

OPTIMOX-aflibercept as First-line Therapy in Patients With Unresectable Metastatic Colorectal Cancer (VELVET)

Unresectable Metastatic Colorectal Cancer

France
GERCOR - Multidisciplinary Oncology Cooperative...
Servier

Terminated

Cardiovascular Events From Trifluridine/Tipiracil +/- Oxaliplatin in Colorectal/Oesogastric Adenocarcinoma Patients

Colorectal Adenocarcinoma | Oesogastric

France
GERCOR - Multidisciplinary Oncology Cooperative...
AstraZeneca

Active, not recruiting

Personalized Maintenance Therapy for m-PDAC Using Olaparib or Selumetinib + Durvalumab, Based on BRCAness and KRAS Status. (MAZEPPA)

Metastatic Pancreatic Adenocarcinoma

France
GERCOR - Multidisciplinary Oncology Cooperative...
AstraZeneca

Active, not recruiting

Durvalumab + Tremelimumab ± Paclitaxel in Advanced BTC After Platinum Chemotherapy. (IMMUNO-BIL)

Advanced Biliary Tract Carcinoma

France
GERCOR - Multidisciplinary Oncology Cooperative...
Pfizer; Ipsen

Unknown

A Study of Sunitinib Versus Placebo in Combination With Lanreotide in Patients With Progressive Advanced/Metastatic Midgut Carcinoid Tumors (SUNLAND)

Carcinoid Tumors

France, Belgium
GERCOR - Multidisciplinary Oncology Cooperative...
Celgene Corporation

Unknown

Efficacy of ABI-007 Plus Gemcitabine or sLV5FU2 as First-line Therapy in Patients With Metastatic Pancreatic Cancer (AFUGEM)

Metastatic Pancreatic Cancer

France
GERCOR - Multidisciplinary Oncology Cooperative...
Fondation ARCAD

Recruiting

Efficacy of Neoadjuvant Chemotherapy in Terms of DFS in Patients With Localized Digestive Neuroendocrine Carcinomas (NEONEC)

Neuroendocrine Carcinoma | Digestive Cancer

France
GERCOR - Multidisciplinary Oncology Cooperative...
OSE Immunotherapeutics

Recruiting

Maintenance With OSE2101 Plus FOLFIRI, or FOLFIRI After FOLFIRINOX-based Induction Therapy in Locally Advanced or Metastatic Pancreatic Ductal Adenocarcinoma (TEDOPAM)

Metastatic Cancer | Pancreatic Ductal Adenocarcinoma | Locally Advanced Cancer

France
GERCOR - Multidisciplinary Oncology Cooperative...
Celgene Corporation

Unknown

NAB-PACLITAXEL Plus FOLFOX as Perioperative Chemotherapy in Patients With Operable Oesogastric Adenocarcinoma (FOXAGAST)

Cancer of Stomach

France
GERCOR - Multidisciplinary Oncology Cooperative...
Merrimack Pharmaceuticals

Completed

A Dose Escalation Study of MM-398 Plus Irinotecan in Patients With Unresectable Advanced Cancer (DOUBLIRI)

Unresectable Advanced Cancer

France
Groupe Hospitalier Diaconesses Croix Saint-Simon
GERCOR - Multidisciplinary Oncology Cooperative Group

Recruiting

Two Therapeutic Strategies in First-line in Patients With Epithelial Advanced Ovarian Cancer (CHIMOVIP)

Ovarian Cancer, Epithelial

France
GERCOR - Multidisciplinary Oncology Cooperative...
Bristol-Myers Squibb

Recruiting

Two Combination Treatment Regimens of Nivolumab and Ipilimumab in Patients With dMMR and / or MSI mCRC. (NIPISAFE)

Colorectal Cancer Metastatic | MSI-H Colorectal Cancer

France
GERCOR - Multidisciplinary Oncology Cooperative...
Roche Pharma AG

Active, not recruiting

A Study of mDCF in Combination or Not With Atezolizumab in Advanced Squamous Cell Anal Carcinoma (SCARCE)

Anal Cancer

France
GERCOR - Multidisciplinary Oncology Cooperative...
Bristol-Myers Squibb

Recruiting

Pre-operative Nivolumab and Ipilimumab, Followed by Post-operative Nivolumab, for MSI/dMMR Oeso-gastric Adenocarcinoma. (NEONIPIGA)

Localized Oesogastric Adenocarcimona | MSI and or dMMR

France
GERCOR - Multidisciplinary Oncology Cooperative...
Hoffmann-La Roche

Active, not recruiting

Multi-Line Therapy Trial in Unresectable Metastatic Colorectal Cancer (STRATEGIC-1)

Colorectal Cancer Metastatic

Ireland, France, Israel
GERCOR - Multidisciplinary Oncology Cooperative...
Bristol-Myers Squibb

Active, not recruiting

iRECIST Evaluation's Relevance for DCR in MMR/MSI Metastatic Colorectal Cancer Patients on Nivolumab and Ipilimumab (NIPICOL)

Metastatic Cancer Colorectal

France
GERCOR - Multidisciplinary Oncology Cooperative...
Hoffmann-La Roche

Completed

Follow up to the AVANT Study up to 8 and 10 Years (Median Follow up) in Patients With Colon Carcinoma

Colon Cancer Treated With Bevacizumab After Colon Surgery

France
GERCOR - Multidisciplinary Oncology Cooperative...

Unknown

Combination Chemotherapy in Treating Patients With Metastatic Colorectal Cancer That Cannot Be Removed By Surgery

Colorectal Cancer

France
GERCOR - Multidisciplinary Oncology Cooperative...

Unknown

Celecoxib or Observation After Radiation Therapy and Chemotherapy in Treating Patients With Stage II or Stage III Non-Small Cell Lung Cancer

Lung Cancer

France
GERCOR - Multidisciplinary Oncology Cooperative...

Unknown

Chemotherapy in Treating Patients With Locally Advanced or Metastatic Cancer of the Pancreas or Bile Duct

Pancreatic Cancer | Extrahepatic Bile Duct Cancer

France, Luxembourg
GERCOR - Multidisciplinary Oncology Cooperative...

Unknown

Docetaxel or Paclitaxel in Treating Women With Unresectable Locally Advanced or Metastatic Breast Cancer

Breast Cancer

France, Luxembourg
GERCOR - Multidisciplinary Oncology Cooperative...

Unknown

Gemcitabine and Docetaxel in Treating Patients With Inoperable Stage IIIB or Stage IV Non-Small Cell Lung Cancer

Lung Cancer

France
GERCOR - Multidisciplinary Oncology Cooperative...

Unknown

Combination Chemotherapy in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer

Lung Cancer

France

Clinical Trials Sponsored by Groupe Cooperateur Multidisciplinaire en Oncologie (GERCOR)

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Kyrgyzstan

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations